WGRX — Wellgistics Health Income Statement
0.000.00%
Last trade - 00:00- $43.88m
- $66.74m
- $18.13m
Annual income statement for Wellgistics Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 0 | 0 | 18.1 |
| Cost of Revenue | |||
| Gross Profit | — | — | 1.77 |
| Selling / General / Administrative Expenses | |||
| Depreciation and Amortization | |||
| Total Operating Expenses | 0.005 | 2.88 | 24.3 |
| Operating Profit | -0.005 | -2.88 | -6.15 |
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | -0.005 | -2.9 | -6.86 |
| Provision for Income Taxes | |||
| Net Income After Taxes | -0.005 | -2.9 | -6.86 |
| Net Income Before Extraordinary Items | |||
| Net Income | -0.005 | -2.9 | -6.86 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | -0.005 | -2.9 | -6.86 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | -0 | -0.056 | -0.145 |